The global dual balloon angioplasty catheter market, valued at USD 199.8 million in 2022, is expected to reach approximately USD 204.9 million in 2023. Projections indicate that the market could experience a compound annual growth rate (CAGR) of 3.2% from 2023 to 2033, potentially reaching a valuation of nearly USD 281.3 million by the end of the forecast period.
Dual balloon angioplasty catheters are essential medical devices used to clear arterial blockages, facilitating blood flow in patients suffering from cardiovascular disorders. This procedure is crucial in preventing heart attacks and angina in individuals with coronary artery disease.
The anticipated growth of the dual balloon angioplasty catheter market is primarily driven by the increasing prevalence of cardiovascular disorders worldwide. Between 2018 and 2022, the market experienced a CAGR of 2%, indicating a steady rise in the adoption of this technology.
Key Market Drivers:
- Rising prevalence of cardiovascular diseases: The growing incidence of heart-related conditions is driving demand for effective treatment options, including dual balloon angioplasty.
- Advancements in medical technology: Innovations in catheter design and functionality are enhancing treatment outcomes and patient safety.
- Increasing awareness and adoption: Greater awareness of cardiovascular health and the benefits of angioplasty procedures is leading to higher adoption rates among healthcare providers.
As the healthcare industry continues to address the challenges posed by cardiovascular diseases, the global dual balloon angioplasty catheter market is poised for substantial growth, providing vital solutions for improving patient health outcomes.
Sometimes, stents are inserted by placing them on the tip of the balloon in the dual balloon angioplasty to keep the artery wall expanded. X-ray is used in dual balloon angioplasty to guide the catheter into the heart and arteries. Dye is injected into the body to highlight the blood arteries. Dual balloon angioplasty catheter resolves the difficulties, such as insertion and removal of the large catheter.
Firm pressure is applied to the site of the catheter to stop the bleeding. Dual balloon angioplasty is usually done when the cholesterol plaque builds up in the wall of the artery of the heart, thus allowing more blood and oxygen to flow into the muscles of the heart.
Market Competition
The global dual balloon angioplasty catheter market features a competitive landscape with several prominent players, including Spectranetics, InSitu Technologies Inc., eucatech AG, Balton Sp. z o.o., PanMed Us, Degania Silicone Ltd., Van Oostveen Medical B.V., IMeSI, phenox GmbH, Natec Medical, Acrostak Int., and SCITECH, Medinol Ltd., among others.
The market is characterized by intense competition due to the presence of these leading companies. Major global entities such as Spectranetics, InSitu Technologies Inc., eucatech AG, Balton Sp. z o.o., PanMed Us, and Degania Silicone Ltd. hold a significant share of the market. Additionally, numerous regional players are active in key growth areas, particularly throughout the Asia Pacific.
In a notable development, Zavation Medical Products, a forward-thinking designer and manufacturer of high-quality spinal implants, instruments, minimally invasive procedural kits, and biologics based in Flowood, MS, announced the launch of its innovative eZspand device, an expandable lumbar interbody fusion solution, in May 2020.
This competitive environment is indicative of the ongoing innovations and advancements in technology that drive the dual balloon angioplasty catheter market forward.
Key Companies Profiled
Spectranetics
InSitu Technologies Inc.
Eucatech AG
Balton Sp.
z o.o.;
PanMed;
Degania Silicone Ltd; Romed Holland; IMeSI; phenox GmbH; Natec Medical; Acrostak; SCITECH; Medinol Ltd.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
